Identification of a novel arylsulfatase B gene mutation in three unrelated Iranian mucopolysaccharidosis type-VI patients with different phenotype severity. (41/74)

 (+info)

Structural, compositional, and biomechanical alterations of the lumbar spine in rats with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). (42/74)

 (+info)

Gene therapy for mucopolysaccharidosis type VI is effective in cats without pre-existing immunity to AAV8. (43/74)

 (+info)

Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses. (44/74)

 (+info)

Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI. (45/74)

 (+info)

Illness perception and clinical treatment experiences in patients with M. Maroteaux-Lamy (mucopolysaccharidosis type VI) and a Turkish migration background in Germany. (46/74)

 (+info)

Haploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome. (47/74)

 (+info)

Sensory-motor behavioral characterization of an animal model of Maroteaux-Lamy syndrome (or Mucopolysaccharidosis VI). (48/74)

 (+info)